WolverHeme Happy Hour

WolverHeme Happy Hour

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(50)

Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

In this episode, Anthony and Bernie begin to recap some interesting studies presented at ASH, starting with a discussion the results of the "Dauno-Double" Trial. Should it change practice? Dauno-Doubl...

14 Joulu 202240min

Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

In this enlightening episode, Anthony and Bernie chat about FLT3+ AML with Dr. Dale Bixby, Clinical Professor and expert in leukemia at the University of Michigan. We use two clinical cases to take a ...

23 Marras 20221h 22min

Episode (3+)7: Straight Outta Roswell - OG AML Data

Episode (3+)7: Straight Outta Roswell - OG AML Data

Finally back from a much needed vacation, in this episode, Anthony and Bernie discuss some of the "OG" data and pharmacology behind key AML therapies.

7 Loka 202247min

Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

In this episode, Bernie and Anthony do an in-depth dive into the pharmacology, toxicity management, and clinical conundrums with asparaginase therapy, including how and when to monitor asparaginase ac...

21 Heinä 20221h 15min

Episode 5: IDH Inhibitors in AML: not so AGILE

Episode 5: IDH Inhibitors in AML: not so AGILE

In this episode, Bernie Marini and Anthony Perissinotti chat with special guest Charles Foucar, MD, a hematology specialist and expert in the field. We discuss the controversial FDA approval of ivosid...

3 Kesä 20221h 24min

Episode 4: All Aboard the Oncology StewardSHIP

Episode 4: All Aboard the Oncology StewardSHIP

In this episode, Bernie Marini and Anthony Perissinotti are joined by two special guest hematology experts - Lydia Benitez, PharmD, BCOP, and Madeleine Ochs, PharmD, BCOP. Maddy and Lydia help us dive...

27 Touko 202255min

Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

In part two of this two-part episode, Bernie Marini and Anthony Perissinotti discuss the use of rituximab in acute lymphoblastic leukemia (ALL), based on the recent publication of the UKALL14 study (M...

22 Huhti 202250min

Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

In part one of a two-part episode, Bernie Marini and Anthony Perissinotti take a journey through the history of acute lymphoblastic leukemia treatment throughout the decades and explain how we got to ...

22 Huhti 202246min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
psykopodiaa-podcast
terapiassa
meditaatiot-suomeksi
rss-seksicast
rss-pitaisko-erota
paritellen
fitnessvastaanotto
junnut-pelissa
rss-pt-paahtio
rss-kuumilla-aalloilla
rss-uplevel-by-sonja-hannus
onnen-kuplia
rss-vapaudu-voimaasi
rss-sanelunpurku-podcast
rss-rentoudu-podcast-rentoutumiseen-hanna-viljanmaa
selviytyjat-tarinoita-elamasta
kehorauhaa